Citius Oncology
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -4,944 | -7,471 | -6,394 | |
Net Income | -5,369 | -7,735 | -6,659 | -6,812 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | 0 | 0 | 0 | |
Cash | ||||
Basic Shares | 71,552 | 71,552 | 71,552 | 71,552 |
Annual Financials
| Values in thousands | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | -20,572 | -12,121 | -4,856 |
Net Income | -21,148 | -12,697 | -5,432 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -4,873 | -601 | -47 |
Cash | 26 | 289 | |
Basic Shares | 71,552 | 89,479 | 90,160 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.08 |
2025-03-31 | -$0.11 |
2024-12-31 | -$0.09 |
2024-09-30 | -$0.30 |
